Slimming pens face coverage hurdle in Brazil Despite booming demand for GLP-1 treatments, insurers and public health system resist adding them to obesity care The pace of growth for sales of GLP-1 hormone analogues in Brazila category that includes blockbusters Wegovy and Mounjarodepends on treatment protocols for obesity that account for multiple options
However, as expected with any drug agent, several adverse effects can occur
It is not a drug, supplement, or food, and it is not intended to diagnose, treat, cure, or prevent any disease
Direct-Pay GLP-1 Programs Without Insurance Requirements PlexusDx operates a direct-pay model that eliminates insurance delays entirely
Both are safe when prescribed by licensed providers
Quick Answer: Zepbound (tirzepatide) does not list dysgeusia as a formal adverse effect, though some patients report taste changes that may be related to gastrointestinal side effects like nausea and reflux